CMS Contemplates Role Of Responding To Device Safety Concerns
This article was originally published in The Pink Sheet Daily
The agency is considering whether product safety issues should be a factor in decisions to repeal Medicare coverage, while some question if this would infringe on FDA turf.
You may also be interested in...
The high-profile COURAGE trial again raises the question of how soon stents should be placed in patients with coronary disease.
NIH and government agencies plan to submit plans to Congress next month describing ways to encourage the development of medical devices for children.
Do not be cavalier about this venue, drug/device lawyer warns.